Back to Search
MARK DAWSON, M.D.
M.D.
Pediatrics Physician
NPI: 1043210271IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Additional
PEDIATRIC MEDICINE
Education
OTHER
Class of 1976
Research & Publications (20)
Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
PMID 19378296·ChemMedChem·2009
8-other
Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma.
PMID 19147779·Clin Cancer Res·2009
4-observational
Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?
PMID 17606456·Haematologica·2007
8-other
An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity.
PMID 17489579·J Med Chem·2007
8-other
AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation--treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A.
PMID 17405744·Haematologica·2007
5-case
Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle.
PMID 17374783·J Gen Virol·2007
7-preclinical
Extramedullary relapse of multiple myeloma presenting as hematemesis and melena.
PMID 16596146·Nat Clin Pract Oncol·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 717 CURTIS DR
RAYNE, LA 70578 - Phone
- (337) 334-7551
Quick Facts
- NPI
- 1043210271
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile